Rocket Pharmaceuticals, Inc.
RCKT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001281895
In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q1 2025
Institutional positions in Rocket Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 236
- +14 vs. Q4 2024
- Shares held
- 107.8M
- −1.67M (−1.5%) vs. Q4 2024
- Total value
- $722.5M
- −$653.0M (−47.5%) vs. Q4 2024
- New holders
- 49
- 111 more added
- Sold out
- 35
- 41 more reduced
3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RCKT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 180 | $340.9M |
| Q1 2026 | 199 | $347.9M |
| Q4 2025 | 186 | $320.0M |
| Q3 2025 | 173 | $314.8M |
| Q2 2025 | 196 | $233.0M |
| Q1 2025 | 236 | $722.5M |
| Q4 2024 | 225 | $1.38B |
| Q3 2024 | 192 | $1.71B |
| Q2 2024 | 178 | $1.96B |
| Q1 2024 | 185 | $2.48B |
| Q4 2023 | 194 | $2.67B |
| Q3 2023 | 175 | $1.83B |
| Q2 2023 | 164 | $1.52B |
| Q1 2023 | 163 | $1.34B |
| Q4 2022 | 168 | $1.49B |
| Q3 2022 | 164 | $1.10B |
| Q2 2022 | 147 | $891.6M |
| Q1 2022 | 149 | $1.02B |
| Q4 2021 | 148 | $1.38B |
| Q3 2021 | 147 | $1.85B |
| Q2 2021 | 150 | $2.74B |
| Q1 2021 | 173 | $2.75B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Rocket Pharmaceuticals, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MYDA Advisors LLC | 460,381 | $3.07M | 1.09% | +460,381 | New |
| Schroder Investment Management Group | 413,550 | $3.14M | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 577,488 | $3.85M | 0.00% | −183,453−24.1% | Reduced |
| Siren, L.L.C. | 591,263 | $3.94M | 0.22% | −8,737−1.5% | Reduced |
| JPMorgan Chase & Co | 610,089 | $4.07M | 0.00% | +94,561+18.3% | Added |
| Nantahala Capital Management, LLC | 629,749 | $4.20M | 0.35% | +629,749 | New |
| UBS Group AG | 647,830 | $4.32M | 0.00% | +77,867+13.7% | Added |
| Woodline Partners LP | 652,865 | $4.35M | 0.03% | +444+0.1% | Added |
| Charles Schwab Investment Management Inc | 675,481 | $4.51M | 0.00% | +19,391+3.0% | Added |
| Northern Trust Corp | 700,301 | $4.67M | 0.00% | +37,149+5.6% | Added |
| Millennium Management LLC | 747,147 | $4.98M | 0.00% | +410,238+121.8% | Added |
| Eventide Asset Management, LLC | 770,691 | $5.14M | 0.10% | 00.0% | Unchanged |
| Comerica Bank | 815,989 | $5.44M | 0.02% | +35,609+4.6% | Added |
| Tang Capital Management LLC | 850,000 | $5.67M | 0.31% | +100,000+13.3% | Added |
| Franklin Resources Inc | 870,308 | $5.80M | 0.00% | +216,749+33.2% | Added |
| Goldman Sachs Group Inc | 995,690 | $6.64M | 0.00% | +192,905+24.0% | Added |
| Frazier Life Sciences Management, L.P. | 1,079,025 | $7.20M | 0.33% | −400,000−27.0% | Reduced |
| Baker Bros. Advisors LP | 1,097,079 | $7.32M | 0.08% | +1,000,000+1,030.1% | Added |
| Toronto Dominion Bank | 1,100,000 | $7.34M | 0.02% | 00.0% | Unchanged |
| Novo Holdings A/S | 1,100,000 | $7.34M | 0.56% | 00.0% | Unchanged |
| Pictet Asset Management Holding SA | 1,317,969 | $8.79M | 0.01% | 00.0% | Unchanged |
| Prosight Management, LP | 1,480,000 | $9.87M | 3.24% | +391,294+35.9% | Added |
| Citadel Advisors LLC | 1,509,004 | $10.1M | 0.01% | −2,613,820−63.4% | Reduced |
| MPM Oncology Impact Management LP | 1,618,265 | $10.8M | 1.86% | +597,706+58.6% | Added |
| Geode Capital Management, LLC | 1,994,044 | $13.3M | 0.00% | +241,069+13.8% | Added |
| Morgan Stanley | 2,641,892 | $17.6M | 0.00% | +1,457,183+123.0% | Added |
| Price T Rowe Associates Inc | 3,043,682 | $20.3M | 0.00% | −104,838−3.3% | Reduced |
| Suvretta Capital Management, LLC | 3,502,000 | $23.4M | 0.95% | +935,049+36.4% | Added |
| State Street Corp | 3,705,461 | $24.7M | 0.00% | +247,382+7.2% | Added |
| Janus Henderson Group PLC | 3,290,843 | $25.0M | 0.01% | −713,196−17.8% | Reduced |
| Westfield Capital Management Co LP | 4,820,701 | $32.2M | 0.16% | +106,091+2.3% | Added |
| Maverick Capital LtdSuperinvestorMaverick Capital | 5,199,218 | $34.7M | 0.62% | +3180.0% | Added |
| Vanguard Group Inc | 6,617,784 | $44.1M | 0.00% | +40,189+0.6% | Added |
| BlackRock, Inc. | 7,274,234 | $48.5M | 0.00% | +176,947+2.5% | Added |
| Wellington Management Group LLP | 12,626,491 | $84.2M | 0.02% | −1,368,686−9.8% | Reduced |
| RTW Investments, LP | 17,687,772 | $118.0M | 1.80% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,569,823−100.0% | Sold out |
| Boxer Capital Management, LLC | 0 | $0 | 0.00% | −1,466,051−100.0% | Sold out |
| Avoro Capital Advisors LLC | 0 | $0 | 0.00% | −1,200,000−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −1,053,300−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −271,659−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −270,983−100.0% | Sold out |
| Ovata Capital Management Ltd | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −159,552−100.0% | Sold out |
| Bamco Inc | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −48,400−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −47,247−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −41,142−100.0% | Sold out |
| one8zero8, LLC | 0 | $0 | 0.00% | −39,700−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −28,441−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −25,147−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −23,193−100.0% | Sold out |
| Aristides Capital LLC | 0 | $0 | 0.00% | −17,400−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −17,588−100.0% | Sold out |
| Quantinno Capital Management LP | 0 | $0 | 0.00% | −12,014−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −10,845−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −6,096−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −5,656−100.0% | Sold out |
| BFSG, LLC | 0 | $0 | 0.00% | −1,900−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −1,320−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −681−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −374−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −269−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −198−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| MRP Capital Investments, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| WealthTrak Capital Management LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |
| Cassady Schiller Wealth Management, LLC | – | – | – | – | Not filed |